European EAP with tailored RWD strategy
READ MORE
Early Access Programs
We are the only specialist Early Access Program partner to harness the full power of an established and successful Contract Research Organization.
We are the only specialist Early Access Program partner to harness the full power of an established and successful Contract Research Organization.
Our Early Access Programs (often called Expanded Access, Pre-approval Access, Compassionate Use, Named Patient or Managed Access Programs) deliver potentially life-saving treatments to patients around the world while adding true value to our clients through a range of additional cutting-edge services.
We are the only specialist Early Access Program (EAP) partner to harness the full power of an established and successful Contract Research Organization. Our global EAP experience in oncology and rare disease areas is perfectly complemented by a range of in-house services.
Patients are at the heart of everything we do. Our vision is to help current and future generations by providing timely and appropriate treatment access to patients in desperate need.
